Triastek, Inc. – Trademark Portfolio
Entity Type: 03
Triastek, Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 5 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include MED, 3DµS, and TRIASTEK.
Room 101, 1F, Building 9,
No. 2 Qiande Road (Jiangning Hi-Tech Park), Jiangning District, Nanjing 210000 Jiangsu
Showing of trademarks Trademarks
Trademark Classifications
Triastek, Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Triastek, Inc. have?
Triastek, Inc. has 7 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 abandoned.
What trademark classes does Triastek, Inc. file in?
Triastek, Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 40 (Treatment & Processing), Class 7 (Machinery). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Triastek, Inc.'s most well-known trademarks?
Triastek, Inc.'s registered trademark portfolio includes well-known marks such as MED, 3DµS, and TRIASTEK. These are among 5 currently registered trademarks in the portfolio.
What is Triastek, Inc.'s trademark registration success rate?
Triastek, Inc. has a 71% trademark registration rate, with 5 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.